SKINOVATION PHARMACEUTICAL INC financial data

Location
Salt Lake City, UT
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2024 - 21 Nov 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 2% % 78%
Debt-to-equity -102% % -0.85%
Return On Equity 10% % 18%
Return On Assets -499% % 34%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 708,000 shares
Common Stock, Shares, Outstanding 708,000 shares 0%
Common Stock, Value, Issued $708 USD 0%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $22,290 USD 55%
Operating Income (Loss) $22,290 USD -55%
Net Income (Loss) Attributable to Parent $45,009 USD -30%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $1,844 USD -81%
Assets, Current $1,844 USD -81%
Assets $1,844 USD -81%
Accounts Payable, Current $10,500 USD 0%
Liabilities, Current $485,095 USD 8.3%
Liabilities $485,095 USD 8.3%
Retained Earnings (Accumulated Deficit) $509,107 USD -9.7%
Stockholders' Equity Attributable to Parent $483,251 USD -10%
Liabilities and Equity $1,844 USD -81%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $3,500 USD 17%
Common Stock, Shares Authorized 50,000,000 shares 0%
Common Stock, Shares, Issued 708,000 shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $3,500 USD -173%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $1,844 USD -81%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 25,000,000 shares 0%
Additional Paid in Capital $25,148 USD 0%
Preferred Stock, Shares Outstanding 0 shares
Interest Expense $22,719 USD 12%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%